Zevra Therapeutics, Inc. logo

Zevra Therapeutics, Inc. (ZVRA)

Market Closed
14 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
12. 05
+0.04
+0.3331%
$
749.28M Market Cap
- P/E Ratio
- Div Yield
611,593 Volume
- Eps
$ 12.01
Previous Close
Add Transaction
Day Range
11.96 12.18
Year Range
7.16 15.04
Want to track ZVRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Zevra Therapeutics, Inc. (ZVRA) Statistics

Valuation metrics

Market Cap 749.28M
Enterprise value 566.15M
Trailing P/E (ttm) 12.51
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 5.22
Price/Book (mrq) 3.26
Enterprise Value/Revenue 4.16
Enterprise Value/EBITDA 7.75

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 872.92K
Average volume (90 days) 1.42M

Price summary

52-Week low 7.16
52-Week high 15.04
Beta -
50-Day moving average 11.2
200-Day moving average 10.3

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:16
Last split Date 28 Dec 2020

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.43%
Operating margin 0.29%

Operational effectiveness

Return on assets 0.19%
Return on equity 0.33%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 2.3
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.98
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 3.75
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 5.17%
Book value per share (mrq) 3.68

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -